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PREFACE 
In the l a s t week in June 1983, more than 250 research s c i e n t i s t s and 
c l i n i c i a n s met at the Faculte Alexis C a r r e l , a School of Medicine 
(University, Claude Bernard, Lyon-I) located in Lyon, France. The 
participants had come from f i f t e e n countries to participate in the 
"Second Symposium sur les Marqueurs de 1' Inf 1 animation" under the 
sponsorship of the "Groupe d
1
Etude et de Recherche sur les Marqueurs de 
1' Inf 1 animation" (GERMI). The topics for t h i s second symposium had been 
chosen by the International S c i e n t i f i c Committee of GERMI in order to 
provide a comprehensive view of the different aspects of the wide f i e l d 
of Marker Proteins in Inflammation and t h e i r c l i n i c a l implications. 
The proceedings begins with a series of papers concerning the mechanism 
of Acute Phase Reactant Proteins synthesis and the roles such proteins 
play in host defenses, a subject of perennial interest which was the 
main theme running throughout the meeting. The next three sections are 
devoted respectively to the protease anti-protease interplay in lung 
diseases, the importance of Acute Phase Proteins measurement in biological 
f l u i d s for the diagnosis of j o i n t diseases, and diseases of the central 
nervous system. The fourth section of the book deals with the role of 
z i n c , protein deprivation, and malnutrition in host defenses. The f i f t h 
section features a group of papers on animal models of inflammation. 
F i n a l l y , the l a s t section of the book reports on conferences held 
during a s a t e l l i t e l e c t i n s workshop arranged by Drs. Michel Caron et 
Alain Faure, which was devoted to three complementary aspects of l e c t i n s : 
their use as a tool for the study of glycoconjugates, their biological 
functions, and their a f f i n i t y and s p e c i f i c i t y . 
We wish to express our deepest gratitude to Professor Frank W. Putnam 
of the department of Molecular Biology and Biochemistry, Indiana 
University (Bloomington, Indiana, USA) who was the outstanding president 
VI 
of this Symposium. We also want to extend our thanks to Professor 
Henry Gewürz, department of Immunology/Microbiology, Rush Medical 
College (Chicago, USA), Professor Robert Engler, department of Bio-
chemistry, UER des Saints Peres ( P a r i s , France) and Professor Roger 
Creyssel, department of Biochemistry UER Grange Blanche (Lyon, France), 
who acted as Symposium Co-Presidents and whose knowledge and under-
standing in the f i e l d made the program and i t s conferences possible. 
We wish to thank the members of the Organizing Committee for thei r 
support and help. This includes Helene Bernon, Jacques Bienvenu, 
Philippe Laurent, Abel Roullet, and J.L. Touraine. The following 
i n s t i t u t i o n s provided financial and practical support: GERMI, I n s t i t u t 
Pasteur de Lyon et du Sud E s t , Fondation Merieux, Societe Francaise 
d
1
Immunologie, Association des Anciens Internes et Internes en 
Pharmacie de Lyon, Commission Medicale Consultative de Hospices C i v i l s 
de Lyon, BioMerieux, Travenol France, Du Pont de Nemours, Hoechst-
Behring, Boehringer Mannheim, Technicon, Roger Bellon. We would also 
l i k e to express our sincere gratitude to Professor Maurice Carraz, 
Director of the Pasteur I n s t i t u t e of Lyon for his important help, and 
Dr. Charles Merieux, who hosted the International S c i e n t i f i c Advisory 
Committee of GERMI and organized the social events. We would l i k e to 
express our thanks to a l l other individuals, companies and i n s t i t u t i o n s 
who contributed to the success of the symposium. 
The fact that expert researchers agreed to write papers on this rather 
new and important subject has made our job a considerable pleasure. We 
also extend our gratitude to the s t a f f of Walter de Gruyter, B e r l i n , 
whose labors have led to the rapid publication of this second volume 
on Marker Proteins in Inflammation. 
February 1984 P. Arnaud 
J . Bienvenu 
P. Laurent 
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I n t r o d u c t i o n 
I n t h e course o f i n f l a m m a t o r y processes s t i m u l a t i o n o f phagocy-
t o s i s and p r o d u c t i o n o f acute phase r e a c t a n t s are c l o s e l y con-
nected. Whereas acute phase p r o t e i n s are s y n t h e s i z e d as r e g u l a -
t o r s o f t h e i n f l a m m a t o r y response d e n o v o by t h e l i v e r 
c e l l s , lysosomal enzymes of phagocytes are p r e f o r m e d 
and can be r e l e a s e d immediately i n t o t h e c i r c u l a t i o n d u r i n g 
f r u s t r a t e d p hagocytosis o r c e l l d i s i n t e g r a t i o n . I n t h i s way, 
e s p e c i a l l y lysosomal p r o t e i n a s e s from PMN g r a n u l o c y t e s l i k e 
e l a s t a s e (E) may cause d e s t r u c t i v e processes b e f o r e t h e y are 
i n a c t i v a t e d by plasma p r o t e i n a s e i n h i b i t o r s , e.g. - p r o t e i n -
ase i n h i b i t o r ( o ^ P I ) . I n c r e a s e d l e v e l s o f t h e E-a^PI complex 
should be, t h e r e f o r e , a c l e a r i n d i c a t i o n o f t he involvement o f 
lysosomal p r o t e i n a s e s i n t he i n f l a m m a t o r y response ( 1 ) . 
M a t e r i a l and Methods 
Using a r e c e n t l y developed enzyme-linked immunoassay (2) we de-
t e r m i n e d the plasma l e v e l s o f E-ot^PI i n 41 p a t i e n t s s u b j e c t e d 
t o major abdominal s u r g e r y as w e l l as i n 27 p a t i e n t s s u f f e r i n g 
from m u l t i p l e trauma. The acute phase r e a c t a n t s C - r e a c t i v e p r o -
t e i n (CRP) , - a n t i c h y m o t r y p s i n (cx^AC) and C 1 - i n a c t i v a t o r 
(C1 INA) were e v a l u a t e d by r a d i a l i m m u n o d i f f u s i o n (LC- o r M-
P a r t i g e n , Behringwerke Marburg, FRG); a - - p r o t e i n a s e i n h i b i t o r 
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(cx^pi) and cc^-plasmin i n h i b i t o r (ct^pi) were measured by t h e i r 
i n h i b i t o r y a c t i o n on t h e t a r g e t enzyme u s i n g chromogenic p e p t i -
de s u b s t r a t e s (Chromozym T r y , Boehringer Mannheim FRG and 
S-2251, Kabi Stockholm, Sweden, r e s p e c t i v e l y ) . 
R esults and D i s c u s s i o n 
Septicemia 
T h i r t y o f 41 p a t i e n t s s u b j e c t e d t o major abdominal s u r g e r y s u f -
f e r e d from s e p t i c e m i a d u r i n g t h e p o s t o p e r a t i v e phase. Of these 
p a t i e n t s 14 s u r v i v e d t h e i n f e c t i o n (group B) whereas the o t h e r 
16 d i e d as a d i r e c t r e s u l t o f s e p t i c e m i a (group C). The 11 pa-
t i e n t s w i t h o u t p o s t o p e r a t i v e i n f e c t i o n served as c o n t r o l s 
(group A ) . 
Abdominal surgery ( F i g . 1) was f o l l o w e d by an i n c r e a s e o f E-a^ 
PI up t o 3 - f o l d o f the mean standa r d v a l u e (60 t o 110 n g / m l ) . 
P a t i e n t s s u f f e r i n g from p r e o p e r a t i v e i n f e c t i o n s (6 o u t o f 16 i n 
group C), showed a l r e a d y s i g n i f i c a n t l y e l e v a t e d p r e o p e r a t i v e E-
ct^PI l e v e l s . Immediately a f t e r s u r g e r y , a s l i g h t decrease was 
observed, p r o b a b l y due t o e l i m i n a t i o n o f t h e i n f e c t i o n f o c u s . 
Before onset of s e p s i s , t h e E-a^PI c o n c e n t r a t i o n s o f groups B 
and C showed a moderate e l e v a t i o n b u t no s i g n i f i c a n t changes 
compared t o the e a r l y p o s t o p e r a t i v e l e v e l s . However, a t t h e be-
g i n n i n g of s e p t i c e m i a a h i g h l y s i g n i f i c a n t i n c r e a s e o f t h e E-
o^PI l e v e l s c o u l d be d e t e c t e d , up t o 6 - f o l d i n group B and up 
t o 1 0 - f o l d i n group C. Peak l e v e l s were found t o be h i g h e r t h a n 
2 500 ng/ml i n b o t h groups. The E-a^PI l e v e l s o f s e p t i c p a t i e n t s 
who recovered showed a c l e a r tendency towards normal v a l u e s . I n 
p a t i e n t s w i t h p e r s i s t i n g s e p t i c e m i a , h i g h l e v e l s o f E-a^PI were 
measured u n t i l death. 
D a i l y measurements o f p r e - and e a r l y p o s t o p e r a t i v e v a l u e s o f 
CRP and E-a^PI i n the c o n t r o l and s e p t i c e m i a groups designed 
b o t h f a c t o r s as b e i n g s i m i l a r l y s e n s i b l e t o t h e i n f l a m m a t o r y 
s t i m u l u s ( F i g . 1 ) . I n c o n t r a s t t o the E-a PI l e v e l s , however, 
the CRP l e v e l s d i d n o t a l l o w d i s c r i m i n a t i o n o f t h e s e v e r i t y o f 
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Fig. 1. Plasma levels of E-o^Pl 
CRP 
complex and CRP i n patients with 
major abdominal surgery. 
A = without pop. I . 
B = survival of pop. I . 
C = death due to pop. I . 
(pop. I . = postoperative infec-
tion) . 
Data are given as mean values 
for the day before operation, 
the day a f t e r operation, the 
period before onset of sepsis 
and the course of septicemia. 
The l a s t determinations were 
done on the days of discharge 
(D) i n group A, recovery (R) i n 
group B, and before death (t) 
i n group C. Normal range (nr) 
of E-ct^PI: 60-110 ng/ml. 
t h e i n f e c t i o n i n the l a t e r p o s t o p e r a t i v e phase, n e i t h e r a t onset 
nor d u r i n g s e p t i c e m i a i n b o t h i n f e c t e d groups; o n l y the l a s t 
v a l u e s were i n agreement w i t h c l i n i c a l o b s e r v a t i o n s . O b v i o u s l y , 
l i b e r a t i o n o f lysosomal e l a s t a s e , p r o b a b l y due t o an enhanced 
a c t i o n o f endotoxins on g r a n u l o c y t e s t h r o u g h o u t s e p t i c e m i a , 
does r e f l e c t more s p e c i f i c a l l y t h i s severe i n f e c t i o n compared 
t o CRP, which i s supposed t o p l a y a c e n t r a l r o l e i n u n s p e c i f i c 
h o s t defence ( 3 ) . 
Moreover, the plasma p r o t e i n a s e i n h i b i t o r s (o^AC, C1 INA, a^PI 
and o>2 P I^ r e p r e s e n t i n g acute phase p r o t e i n s d i d a l s o n o t r e -
f l e c t t h e morbid s t a t e , l i k e l y due t o an o v e r l a p of p r o d u c t i o n 
and consumption of these g l y c o p r o t e i n s (data n o t shown). 
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M u l t i p l e trauma 
I n a p r e l i m i n a r y study r e l e a s e of g r a n u l o c y t i c e l a s t a s e i n t o 
plasma was f o l l o w e d up every 4 hours i n p a t i e n t s who s u f f e r e d 
from m u l t i p l e trauma. The i n c r e a s e of the E-ct^PI complex up t o 
16 hours a f t e r a c c i d e n t c o i n c i d e d c l e a r l y w i t h the s e v e r i t y o f 
the i n j u r y ( F i g . 2 ) , t h e degree o f i n j u r y b e i n g e s t a b l i s h e d on 
the b a s i s o f a h o s p i t a l i n t e r n a l s c a l e r a n g i n g from 1-20 p o i n t s . 
Group I p a t i e n t s (5 t o 7 p o i n t s ) showed a maximal i n c r e a s e o f 
E-a^PI up t o 5 - f o l d above normal v a l u e s and group I I p a t i e n t s 
(9 t o 11 p o i n t s ) up t o 1 0 - f o l d . I n group I I I (14 t o 17 p o i n t s ) 
peak l e v e l s h i g h e r t han 2 0 - f o l d above normal were measured. 
During the f u r t h e r o b s e r v a t i o n p e r i o d (up t o 100 h) a s i g n i f i -
c a n t decrease of E-a^PI plasma l e v e l s towards normal v a l u e s was 
observed i n a l l p a t i e n t s . 
C-reoctive Protein (CRP) F i g . 2. Plasma l e v e l s o f 
E-ct^PI complex and CRP i n 
p a t i e n t s a f t e r m u l t i p l e 
trauma. On t h e b a s i s o f a 
h o s p i t a l i n t e r n a l s c a l e 
w i t h 20 p o i n t s (HISP)pa-
t i e n t s were a l l i e d t o 3 
groups r e f l e c t i n g t h e se-
v e r i t y o f i n j u r y : I m i l d ; 
I I severe; I I I h i g h l y se-















Normal range of E-a^PI: 
6 0 - 1 1 0 ng/ml 
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Maximal i n c r e a s e o f CRP l e v e l s was observed n o r m a l l y between 
20 and 40 h a f t e r a c c i d e n t (group I and I I i n F i g . 2 ). I n a few 
cases (group I I I ) maximal CRP v a l u e s were measured up t o 88 h 
a f t e r trauma ( F i g . 2 ). W i t h i n t h e o b s e r v a t i o n p e r i o d , t h e CRP 
l e v e l s showed n e i t h e r a s t a t i s t i c a l l y s i g n i f i c a n t c o r r e l a t i o n 
t o t h e s e v e r i t y of t h e i n j u r i e s nor a c l e a r tendency towards 
n o r m a l i z a t i o n . The same h o l d s t r u e f o r t h e plasma p r o t e i n a s e 
i n h i b i t o r s responding as acute phase p r o t e i n s (data n o t shown). 
I n c o n t r a s t t o r e s u l t s p u b l i s h e d r e c e n t l y ( 4 ), we c o u l d so f a r 
n o t f i n d a r e l a t i o n s h i p between t h e amount o f CRP i n plasma and 
p o s t t r a u m a t i c c o m p l i c a t i o n s a f t e r c r a n i o - c e r e b r a l i n j u r i e s . 
Conclusions 
A l t h o u g h o f a l l known acute phase p r o t e i n s CRP r i s e s most d r a -
m a t i c a l l y and r a p i d l y , t h e g i v e n d a t a demonstrate t h a t complexed 
e l a s t a s e (E-cx^PI) r e f l e c t s t h e s e v e r i t y of an i n f l a m m a t o r y r e -
sponse c l e a r l y e a r l i e r and more s p e c i f i c a l l y . Hence, compared 
t o lysosomal e l a s t a s e i n c r e a s e d p r o d u c t i o n o f acute phase p r o -
t e i n s , a t l e a s t o f CRP, r e p r e s e n t s a delayed and l e s s s p e c i f i c 
answer o f t h e organisms t o the p r i m a r y i n f l a m m a t o r y s t i m u l i 
d u r i n g diseases such as s e p t i c e m i a and m u l t i p l e trauma. 
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